Showing 6811-6820 of 10228 results for "".
- Survey Highlights Risks of Pubic Hair Groominghttps://practicaldermatology.com/news/survey-highlights-risks-of-pubic-hair-grooming/2458086/More than one-quarter of people who groom their pubic hair sustain grooming-related injuries, according to a new article published by JAMA Dermatology. Of the 7,570 men and women who completed
- Isdin Launches Nutraseb™ for Facial Seborrheic Dermatitishttps://practicaldermatology.com/news/isdin-launches-nutraseb-for-facial-seborrheic-dermatitis/2458089/Isdin is rolling out Nutraseb™ Facial Cream, a new steroid-free topical Rx for the multi-symptom management of facial seborrhea and seborrheic dermatitis (SD). Nutraseb™ is a fragranc
- Revision Skincare Launches Nectifirm Advancedhttps://practicaldermatology.com/news/revision-skincare-launches-nectifirm-advanced/2458090/Revision Skincare® is expanding the Nectifirm® collection with Nectifirm® ADVANCED. Nectifirm® ADVANCED harnesses the power of the Microbiome for maintaining skin
- New Criteria Aims to Help Doctors Spot Amelanotic Melanoma Earlierhttps://practicaldermatology.com/news/new-criteria-aims-to-help-doctors-spot-amelanotic-melanoma-earlier/2458092/New research outlines key features linked to amelanotic melanoma. The findings, which appear in JAMA Dermatology, may help improve detection of this type of melanoma, which is more likely to be diagnosed at advanced stages because it falls outside of the “ABCDE” guide
- Review Study Suggests Vitamin B3 May Prevent Melanomahttps://practicaldermatology.com/news/review-study-suggests-vitamin-b3-may-prevent-melanoma/2458093/Nicotinamide (Vitamin B3) may help stave off melanoma in high-risk individuals, a new review study suggests. “Nicotinamide has been shown in a clinical trial—called ONTRAC—to reduce the incidence of non-melanoma skin cancer in high-risk individuals and it would be worthw
- Research on Nitric Oxide-Releasing Nanoparticles Reveals Promising Skin Infection Treatmenthttps://practicaldermatology.com/news/research-on-nitric-oxide-releasing-nanoparticles-reveals-promising-skin-infection-treatment/2458095/George Washington University (GW) researchers have found that topically applied nitric oxide-releasing nanoparticles (NO-np) are a viable treatment for deep fungal infections of the skin caused by dermatophyt
- Serica: New Formulations Target Scars, Stretch Marks with Rain-forest Sourced Ingredientshttps://practicaldermatology.com/news/serica-new-formulations-target-scars-stretch-marks-with-rain-forest-sourced-ingredients/2458099/Serica Moisturizing Scar Formula and Serica Moisturizing Stretch Mark Formula from Cynova Laboratories, formulated with a special blend of ingredients, including Amazonian Pracaxi oil and a patented network of semipermeable silicones, are intended to help to
- Aclaris Submits Marketing Authorization Application in Europe for A-101 40% for Seborrheic Keratosishttps://practicaldermatology.com/news/aclaris-submits-marketing-authorization-application-in-europe-for-a-101-40-for-seborrheic-keratosis/2458100/Aclaris Therapeutics, Inc. has submitted a Marketing Authorization Application (MAA) with the Medicines Product Agency (MPA) in Sweden for its product candidate A-101 40% Topical Solution for the treatment of seborrheic keratosis. The MPA will act as the reference member state in this decentraliz
- MKTP Surgery Shows Long-Term Benefit for Restoring Skin Pigmentation in Vitiligohttps://practicaldermatology.com/news/mktp-surgery-shows-long-term-benefit-for-restoring-skin-pigmentation-in-vitiligo/2458103/Melanocyte-keratinocyte transplantation (MKTP) provides long-term benefits for restoring skin pigmentation caused by vitiligo, report researchers from Henry Ford Hospital in Detroit. “MKTP works and it lasts a long time,” says Iltefat Hamzavi, M.D., a Henry Ford dermatologist
- Cutanea Life Sciences Unveils Facing Forward Mobile App for Acne Patientshttps://practicaldermatology.com/news/cutanea-life-sciences-unveils-facing-forward-new-mobile-app-for-acne-patients/2458104/Cutanea Life Sciences, Inc. introduced its Facing Forward mobile application for patients who are prescribed Aktipak (erythromycin and benzoyl peroxide) Gel, 3%/5%, a combination therapy indicated for the topical treatment of acne vulgaris. The app will be available free thro